Back to Search
DAVID CASTELLANO, MD
MD
Ophthalmology Physician
NPI: 1639112691IndividualAccepts Medicare
Education
GEISEL SCHOOL OF MEDICINE AT DARTMOUTH
Class of 1991
Research & Publications (20)
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.
PMID 19615940·Lancet Oncol·2009
3-trial
Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-{alpha} as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population.
PMID 19549706·Ann Oncol·2009
3-trial
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of metastatic renal cancer.
PMID 19259675·Cancer Chemother Pharmacol·2009
6-review
Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
PMID 17169762·Clin Transl Oncol·2006
2-rct
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.
PMID 17156477·BMC Cancer·2006
3-trial
Structure-activity relationship (SAR) studies of benzoxazinones, their degradation products, and analogues. Phytotoxicity on problematic weeds Avena fatua L. and Lolium rigidum Gaud.
PMID 16478215·J Agric Food Chem·2006
8-other
Stridor and dysphagia in diffuse idiopathic skeletal hyperostosis (DISH).
PMID 16467731·Laryngoscope·2006
5-case
Application of Hansch's model to guaianolide ester derivatives: a quantitative structure-activity relationship study.
PMID 15853398·J Agric Food Chem·2005
8-other
Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial.
PMID 15701857·Clin Cancer Res·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 915 OLENTANGY RIVER RD FL 5
COLUMBUS, OH 43212 - Phone
- (614) 293-8116
Quick Facts
- NPI
- 1639112691
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile